NovoSci's dual-lumen disposable haemodialysis catheters:
This article was originally published in Clinica
Executive Summary
US firm NovoSci has received 510(k) clearance from the US FDA to sell its dual-lumen short-term haemodialysis catheters. The D-Line catheters, for use in patients with end-stage renal disease (ESRD), are already available in Europe, South America and Asia. The single-use, disposable products are used to access a patient's vein to direct blood towards the haemodialysis machine. They are made from polyurethane to resist kinks, and have a smaller bore than previous models, to enhance patient comfort. The US has the largest population of ESRD patients in the world, with over 400,000 sufferers requiring either kidney dialysis or transplantation, claimed the firm, based in The Woodlands, Texas.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.